Teijin Pharma Aims at Chinese Market For Equipment And Drug Trials
This article was originally published in PharmAsia News
Executive Summary
The Japanese company Teijin Pharma says it plans to ask within the year for Chinese authorization to import medical equipment and start clinical drug trials